SCHEMBL15322335

SCHEMBL15322335

CN(C)CC(N)c1cc(F)cc(-c2cncc([N+](=O)[O-])c2N)c1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15301947 0.77 CLK2 (0.40) —
SCHEMBL30143698 0.77 CLK2 (0.40) —
SCHEMBL15325678 0.75 MAPT (0.35) MAPT
SCHEMBL15365948 0.74 MAPT (0.39) MAPT
SCHEMBL15307252 0.72 CLK2 (0.42) —
SCHEMBL17596983 0.72 GBA1 (0.31) —
SCHEMBL19678629 0.70 CSNK1D (0.43) MAPT
SCHEMBL15365445 0.69 MAP4K4 (0.45) MAPT
SCHEMBL23360961 0.69 GBA1 (0.46) —
SCHEMBL15365950 0.65 MAPT (0.36) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760285-A1 INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF Samumed, LLC (US) 2014-08-06 — — EP disclosed
WO-2013151708-A1 INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF SAMUMED, LLC (US) 2013-10-10 — — WO disclosed
Send feedback